B87-67447-99983
4 vaccinations
5 coded responses
12 check-ins
5 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 66+
- ZIP prefix
- 385 / TN
- Registered
- 2021-03-02
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-15
Dose 1 — Pfizer-BioNTech
-
2021-02-15
Dose 2 — Pfizer-BioNTech
-
2021-03-02
Registered in v-safe
- 2021-03-02
- 2021-03-09
- 2021-03-15
- 2021-03-24
-
2021-03-29
Survey response — day 42, dose 2MedDRA: Back pain — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Lower back extreme painMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-17
Survey response — 3 months, dose 2MedDRA: Rhinorrhoea — Feeling: GoodFree text: My nose runs excessively when I eat a meal. Afterwards, I dont have that condition until I eat again. This seems to have started after my second COVID19 shot. I didnt have it before and I thought it would clear up, but it has continued.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-08-16
Survey response — 6 months, dose 2MedDRA: Diabetes mellitus, Pre-existing disease — Feeling: FairFree text: Diabetic glucose readings have been elevated.MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-09-30
Dose 3 — Pfizer-BioNTech
-
2022-02-15
Survey response — 12 months, dose 2MedDRA: Arthralgia, Gait disturbance, Muscular weakness — Feeling: Good · Be unable to do your normal daily activitiesFree text: Weakness and soreness in my left hip. I don't attribute it to the COVID vaccine. It has made walking a little difficult but not impossible.MedDRA releases: 2024-11 · check-in free text available
- 2022-04-01
-
2022-06-17
Dose 4 — Moderna
-
2022-10-01
Survey response — 12 months, dose 3MedDRA: Arthralgia, Muscular weakness, Pain in extremity — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Soreness/Weakness in left hip and legMedDRA releases: 2024-11 · check-in free text available
- 2022-12-16
- 2023-06-17
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-15 | Pfizer-BioNTech | |
| 2 | 2021-02-15 | Pfizer-BioNTech | |
| 3 | 2021-09-30 | Pfizer-BioNTech | No |
| 4 | 2022-06-17 | Moderna | No |
Free text
Release 6 — day 42, dose 2
Symptoms: Lower back extreme pain
Release 8 — 3 months, dose 2
Symptoms: My nose runs excessively when I eat a meal. Afterwards, I dont have that condition until I eat again. This seems to have started after my second COVID19 shot. I didnt have it before and I thought it would clear up, but it has continued.
Release 9 — 6 months, dose 2
Symptoms: Diabetic glucose readings have been elevated.
Release 11 — 12 months, dose 2
Symptoms: Weakness and soreness in my left hip. I don't attribute it to the COVID vaccine. It has made walking a little difficult but not impossible.
Release 12 — 12 months, dose 3
Symptoms: Soreness/Weakness in left hip and leg
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Arthralgia | · | · | ✓ |
| SD | Back pain | ✓ | ✓ | ✓ |
| SD | Diabetes mellitus | ✓ | · | ✓ |
| SD | Gait disturbance | · | · | ✓ |
| SD | Muscular weakness | · | · | ✓ |
| SD | Pain in extremity | · | · | ✓ |
| SD | Pre-existing disease | ✓ | · | ✓ |
| SD | Rhinorrhoea | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release